Jinghan Wang
83 Fenyang Road
Shanghai, 200031, China
Shanghai, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Correction: YTHDC1 modulates the malignant phenotype of retinoblastoma via SQSTM1-mediated autophagy.
Journal: Scientific reports
Published: April 30, 2026
YTHDC1 modulates the malignant phenotype of retinoblastoma via SQSTM1-mediated autophagy.
Journal: Scientific reports
Published: November 11, 2025
Gene Therapy vs Cochlear Implantation in Restoring Hearing Function and Speech Perception for Individuals With Congenital Deafness.
Journal: JAMA neurology
Published: July 21, 2025
Key indicators for guiding tocilizumab therapy to prevent orbital decompression surgery in hormone-resistant dysthyroid optic neuropathy.
Journal: Frontiers in immunology
Published: January 07, 2025
PDK2-enhanced glycolysis aggravates fibrosis via IL11 signaling pathway in Graves' orbitopathy.
Journal: Frontiers in immunology
Published: November 30, 2024
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 21, 2024
Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results.
Journal: Nature medicine
Published: December 15, 2023
AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial.
Journal: Lancet (London, England)
Published: November 08, 2023
Development and evaluation of multimodal AI for diagnosis and triage of ophthalmic diseases using ChatGPT and anterior segment images: protocol for a two-stage cross-sectional study.
Journal: Frontiers in artificial intelligence
Published: October 18, 2023
Preclinical evaluation of the efficacy and safety of AAV1-hOTOF in mice and nonhuman primates.
Journal: Molecular therapy. Methods & clinical development
Published: August 25, 2023
Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells.
Journal: Cell communication and signaling : CCS
Published: August 14, 2023
Last Updated: 09/26/2026